Find Ampalex manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 154235-83-3, Piperidin-1-yl(quinoxalin-6-yl)methanone, Cx-516, Cx516, Bdp 12, 1-(quinoxalin-6-ylcarbonyl)piperidine
Molecular Formula
C14H15N3O
Molecular Weight
241.29  g/mol
InChI Key
ANDGGVOPIJEHOF-UHFFFAOYSA-N
FDA UNII
Z5QU38B4V9

Ampalex
1 2D Structure

Ampalex

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
piperidin-1-yl(quinoxalin-6-yl)methanone
2.1.2 InChI
InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2
2.1.3 InChI Key
ANDGGVOPIJEHOF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2
2.2 Other Identifiers
2.2.1 UNII
Z5QU38B4V9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(quinoxalin-6-ylcarbonyl)piperidine

2. Bdp 12

3. Bdp-12

4. Cx516

2.3.2 Depositor-Supplied Synonyms

1. 154235-83-3

2. Piperidin-1-yl(quinoxalin-6-yl)methanone

3. Cx-516

4. Cx516

5. Bdp 12

6. 1-(quinoxalin-6-ylcarbonyl)piperidine

7. 1-(6-quinoxalinylcarbonyl)piperidine

8. Bdp-12

9. Cx 516

10. Abt-224

11. Piperidine, 1-(6-quinoxalinylcarbonyl)-

12. 6-(piperidine-1-carbonyl)quinoxaline

13. 1-piperidyl(quinoxalin-6-yl)methanone

14. Chembl136800

15. Z5qu38b4v9

16. 173047-75-1

17. Chebi:34605

18. 287399-47-7

19. 1-(quinoxalin-6-ylcarbonyl)-piperidine

20. Piperidin-1-yl-quinoxalin-6-yl-methanone

21. Unii-z5qu38b4v9

22. Spd-420

23. Ampakine Cx516

24. 1-piperidinyl-6-quinoxalinylmethanone

25. Ampalex-[d10]

26. Bdp-12(ampalex)

27. Ampalex (cx-516)

28. Ampalex, Cx-516

29. Schembl194605

30. Gtpl4165

31. Zinc6489

32. Ampalex I(1/4)oecx-516

33. Dtxsid70165574

34. Ex-a265

35. Amy14816

36. Bcp04606

37. Ac-001

38. Bdbm50094009

39. Mfcd00943201

40. Akos008927689

41. 1-piperidinyl-6-quinoxalinyl-methanone

42. Bcp9000296

43. Cs-1086

44. Db06247

45. Ds-1548

46. Fs-3368

47. 6-[(piperidin-1-yl)carbonyl]quinoxaline

48. Ncgc00371146-01

49. Cx516, >=98% (hplc)

50. Hy-10933

51. Bcp0726000046

52. Ft-0657266

53. Vu0430675-1

54. 235a833

55. J-009084

56. Q5014875

57. Cx5

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 241.29 g/mol
Molecular Formula C14H15N3O
XLogP31.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass241.121512110 g/mol
Monoisotopic Mass241.121512110 g/mol
Topological Polar Surface Area46.1 Ų
Heavy Atom Count18
Formal Charge0
Complexity301
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in alzheimer's disease, memory loss, autism, neurologic disorders, dementia, schizophrenia and schizoaffective disorders, attention deficit/hyperactivity disorder (ADHD), and sleep disorders.


5 Pharmacology and Biochemistry
5.1 Mechanism of Action

CX 516 is a benzylpiperidine AMPAkine, an AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) modulator, that enhances the function of glutamate when it binds allosterically to the AMPA receptor channel complex. CX 516 slows receptor deactivation with a longer open time, slower excitatory postsynaptic potential (EPSP) decay and improvement of hippocampal long term potentiation (LTP).


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty